Source: Health Canada shortage reports · Updated Jul 28, 2026
Some Apixaban products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jul 31, 2026.
A blood thinner used to prevent and treat blood clots.
Products affected
1 / 10
In shortage since
Jul 27, 2026
Est. full return
Jul 31, 2026
Reports on file
31
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · since Jul 27, 2026, est. end Jul 31, 2026 · Delay in shipping of the drug.
Active shortage
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · since Jul 27, 2026, est. end Jul 31, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 23, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Mar 20, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Feb 2, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
TARO-APIXABAN
5MG · TABLET · SUN PHARMA CANADA INC
DIN 02510472 · ended Jan 21, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ APIXABAN SDZ
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489228 · ended Jan 8, 2026 · Delay in shipping of the drug.
Resolved
SANDOZ APIXABAN SDZ
5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02489236 · ended Dec 12, 2025 · Disruption of the manufacture of the drug.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 27, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487721 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
ACH-APIXABAN
2.5MG · TABLET · ACCORD HEALTHCARE INC
DIN 02487713 · ended Nov 21, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
M-APIXABAN
5MG · TABLET · MANTRA PHARMA INC
DIN 02529017 · ended Aug 25, 2025 · Delay in shipping of the drug.
Showing 12 of 31 reports. All reports are on file with Health Canada.
What's happening
Apixaban is currently affected by an active shortage report filed with Health Canada by SANDOZ CANADA INCORPORATED.
The reported cause is: delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Apixaban is classified under “ANTITHROMBOTIC AGENTS” (ATC B01AF).
Recent changes
Jul 28, 2026
New report filed
Jul 28, 2026
New report filed
Common questions
What is Apixaban used for?
A blood thinner used to prevent and treat blood clots.
When will Apixaban be back in stock in Canada?
The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Apixaban in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.